You have 9 free searches left this month | for more free features.

lucentis

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration
  • BAT5906 injection
  • Lucentis
  • (no location specified)
Jun 26, 2022

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg

Completed
  • Age-Related Macular Degeneration
  • 2.0 mg DE-122 Injectable Solution + Lucentis
  • +2 more
  • Gilbert, Arizona
  • +13 more
Jun 22, 2021

Wet Age-related Macular Degeneration Trial in Chengdu (MW02, Lucentis)

Recruiting
  • Wet Age-related Macular Degeneration
  • Chengdu, Si Chuan, China
    West China Hospital of Sichuan University
Mar 17, 2022

Wet Age-related Macular Degeneration Trial in Hungary, Latvia, United States (Zimura, Lucentis)

Completed
  • Wet Age-related Macular Degeneration
  • Phoenix, Arizona
  • +27 more
Feb 3, 2022

Nonproliferative Diabetic Retinopathy Trial (Lucentis)

Completed
  • Nonproliferative Diabetic Retinopathy
  • Lucentis
  • (no location specified)
May 8, 2020

Patterns With Lucentis® in Real-life Conditions in All Approved

Completed
  • Neovascular (Wet) Age-related Macular Degeneration
  • Lucentis
  • Ettlingen, Baden Wuerttemberg, Germany
  • +174 more
Apr 12, 2021

Diabetic Macular Edema, Cataract Trial in Shanghai (Lucentis)

Unknown status
  • Diabetic Macular Edema
  • Cataract
  • Lucentis
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 25, 2020

Age Related Macular Degeneration Trial in China (HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized

Recruiting
  • Age Related Macular Degeneration
  • HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
  • Lucentis
  • Bengbu, Anhui, China
  • +40 more
Apr 27, 2022

Age Related Macular Degeneration Trial in Lyon (Avastin, Lucentis)

Completed
  • Age Related Macular Degeneration
  • Lyon, France
    Service d'Ophtalmologie - Hôpital de la Croix Rousse
May 23, 2019

Wet Age-related Macular Degeneration Trial in Shanghai (lucentis, QL1205)

Completed
  • Wet Age-related Macular Degeneration
  • Shanghai, Shanghai, China
    Shanghai General Hospital, Shanghai Jiao Tong University School
Apr 10, 2019

Proliferative Diabetic Retinopathy Patients

Unknown status
  • Proliferative Diabetic Retinopathy
  • Panretinal Photocoagulation
  • Lucentis
  • Baltimore, Maryland
    Elman Retina Group
Feb 6, 2019

Diabetic Macular Edema Trial in Toronto (Ozurdex, Lucentis)

Terminated
  • Diabetic Macular Edema
  • Toronto, Ontario, Canada
  • +1 more
Aug 17, 2018

Wet Macular Degeneration Trial in Seoul (Lucentis)

Completed
  • Wet Macular Degeneration
  • Lucentis
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 17, 2018

Age Related Macular Degeneration Trial (Visudyne, Lucentis, Dexamethasone)

Withdrawn
  • Age Related Macular Degeneration
  • (no location specified)
Aug 21, 2017

Assessment of Color Vision in Diabetic Patients

Completed
  • Retinopathy, Diabetic
  • lucentis
  • Goiânia, Goias, Brazil
    Instituto de Olhos de Goiania
Nov 16, 2017

Age-Related Macular Degeneration Trial in West Columbia (E10030 plus Lucentis, Lucentis)

Completed
  • Age-Related Macular Degeneration
  • E10030 plus Lucentis
  • Lucentis
  • West Columbia, South Carolina
    Palmetto Retinal Center
Apr 6, 2017

Age Related Macular Degeneration (AMD) Trial in Remuera, Auckland (Lucentis, PF582)

Completed
  • Age Related Macular Degeneration (AMD)
  • Remuera, Auckland, New Zealand
  • +1 more
May 9, 2016

Diabetic Macular Edema Trial in Vienna (Bevacizumab (Avastin), Triamcinolone, Sham)

Completed
  • Diabetic Macular Edema
  • Bevacizumab (Avastin)
  • +3 more
  • Vienna, Austria
    Dept. of Ophthalmology, Medical University of Vienna
Mar 3, 2016

Age-Related Macular Degeneration (AMD) Trial in United States (PAN-90806 Ophthalmic Solution, Lucentis)

Completed
  • Age-Related Macular Degeneration (AMD)
  • PAN-90806 Ophthalmic Solution
  • Lucentis
  • Colorado Springs, Colorado
  • +21 more
Sep 27, 2016

Study Evaluating Genotypes Using Lucentis

Terminated
  • Age-Related Maculopathy
  • Lucentis
  • Santa Barbara, California
  • +2 more
Feb 10, 2015

Exudative Macular Degeneration, Diabetic Macular Edema Trial in Grand Rapids (Avastin, Lucentis)

Completed
  • Exudative Macular Degeneration
  • Diabetic Macular Edema
  • Grand Rapids, Michigan
    Vitreo-Retinal Associates
Dec 16, 2014

Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration Trial in Milano (Iray, Lucentis)

Unknown status
  • Retinal Pigment Epithelial Detachment With Vascularization
  • Age Related Macular Degeneration
  • Iray
  • Lucentis
  • Milano, Italy
    Università Vita-Salute Istituto Scientifico San Raffaele
Oct 24, 2012

Investigates Improvement in Vision Following Switching From

Completed
  • Wet AMD
  • Lucentis
  • Honolulu, Hawaii
    Retina Institute of Hawaii
May 24, 2012

Retinal Vein Occlusion Trial in Vienna (Lucentis)

Completed
  • Retinal Vein Occlusion
  • Lucentis
  • Vienna, Austria
    Vienna General Hospital
Dec 7, 2009